You simply cannot state that as fact. They could have had multiple other RTEs. Should I dare mention Honeywell or other names that have been thrown around here or in a conference call? They have highlighted some positive events, yes, but cannot take this away from entirety of company and ignore upcoming dilution, a burn rate that will require funding each quarter, still no commercial sales. An RTE timeline that is SIGNIFICANTLY longer than anticipated by shareholders, along with now there are stages....that was never announced earlier and frankly think it is indication that they are simply bumbling through the development of the product. In short, they are likely a long way off before become profitable. I honestly think the best investors can hope for at this point is that the revenue continue to increase (hopefully faster) and dilutive offerings/raises are slowed/stopped. In short, still see it heading into 1 dollar range and staying around 1.50 to 1.75 given upcoming dilution.
Again, always hope for shareholders here, but they have been disappointed all too many times.
News 
Market Data 
Discover 
